IMMU-46. GLIOBLASTOMA PATIENT DIAGNOSES AND IMMUNOSUPPRESSION ARE MAXIMAL DURING OLD AGE: A RANDOM COINCIDENCE, OR CAUSE AND EFFECT?

INTRODUCTION: Immunotherapy fails to improve overall survival (OS) of adults with glioblastoma (GBM) according to recent Phase III clinical trial outcomes. Though immune checkpoint blockade improves OS among patients diagnosed with other, end-stage, non-CNS cancers (ie. melanoma, renal, etc.), there...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Ladomersky, Erik, Otto-Meyer, Sebastian, Zhai, Lijie, Savoor, Rohan, Lauing, Kristen, Lenzen, Alicia, Lukas, Rimas, Wainwright, Derek
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6216456/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.549
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados